New home for Novo's Parkinson's cell therapy; GSK turns to China for hep B drug
Plus, label expansions for two drugs targeting rare diseases, and Genmab scraps a Phase 1 cancer trial: š§ Novo's Parkinson's cell therapy finds a biotech home: Novo Nordisk has found a home for an early-stage ...
ORIGINAL SOURCE āvia Endpoint News
ADVERTISEMENT
ā” STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING āRELATED Ā· CN
- [HEALTH] Who writes the pandemic? State power, individual subjectivity, and the history of the present in China's COVID-19 respon
- [CONFLICT] SON DAKÄ°KA HABERÄ°: Ćin'den ABD'nin yaptırım kararına tepki
- [CONFLICT] GSK cuts deal with Sino to broaden reach of hepatitis B drug
- [TECH] Trump invites Elon Musk, Tim Cook, Larry Fink and other CEOs to join China trip for Xi summit
- [CONFLICT] China maintains its position on resolving Ukrainian crisis ā Foreign Ministry
- [CONFLICT] Elon Musk, Tim Cook To Be Part Of Team Trump For Key China Tour: Report